"Das AGAPLESION DIAKONIEKLINIKUM ROTENBURG gemeinnützige GmbH ist das größte konfessionelle Krankenhaus in Niedersachsen und akademisches Lehrkrankenhaus der Medizinischen Fakultät der Universität Hamburg. Als Maximalversorger mit rund 185.000 Patientenkontakten im Jahr bietet es nahezu das gesamte Spektrum moderner Krankenhausmedizin. Die fortschrittliche Hochleistungsmedizin und die professionelle Pflege mit ihren christlichen Wurzeln zeichnen das Haus aus. Das Diakonieklinikum ist zertifiziertes „Überregionales Traumazentrum“ zur Behandlung von Schwerverletzten, zertifiziertes Endoprothetik- und Gefäßzentrum sowie Epilepsiezentrum und Medizinisches Zentrum für Erwachsene mit Behinderung. Einen besonderen Schwerpunkt bildet die Onkologie."

During the past decade, Diakoniekrankenhaus Rotenburg conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diakoniekrankenhaus Rotenburg" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Hannover Medical School" with 2 trials sponsored, "Technische Universität Dresden" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diakoniekrankenhaus Rotenburg" #1 collaborator was "Bayer" with 1 trials as a collaborator, "CAPNETZ Stiftung" with 1 trials as a collaborator, "Central European Cooperative Oncology Group" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator and "German Association of Urologic Oncology" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Diakoniekrankenhaus Rotenburg" are "Breast Neoplasms" (2 trials), "Abdominal Wound Healing Disorder" (1 trials), "Abdominal Wound Healing Impairment" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials) and "Acute Postsurgical Subcutaneous Wound" (1 trials). Many other conditions were trialed in "Diakoniekrankenhaus Rotenburg" in a lesser frequency.

Most popular intervention types in "Diakoniekrankenhaus Rotenburg" are "Drug" (11 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (3 trials), "Docetaxel" (2 trials), "Pertuzumab" (2 trials), "Trastuzumab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diakoniekrankenhaus Rotenburg" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Diakoniekrankenhaus Rotenburg". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Diakoniekrankenhaus Rotenburg, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Diakoniekrankenhaus Rotenburg, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".